[In Process Citation].

[In Process Citation]. Lakartidningen (2015) 0.75

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis (2010) 3.46

Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch Intern Med (2010) 2.42

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis (2007) 1.92

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59

Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J Psychiatr Res (2013) 1.50

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol (2005) 1.49

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 1.47

Osseointegrated titanium implants for limb prostheses attachments: infectious complications. Clin Orthop Relat Res (2010) 1.42

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis (2013) 1.42

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis (2007) 1.36

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol (2009) 1.32

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther (2005) 1.28

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol (2006) 1.24

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes. J Med Chem (2004) 1.24

CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration. J Neurol (2007) 1.22

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy. J Acquir Immune Defic Syndr (2010) 1.15

Lactobacillus-mediated interference of mutans streptococci in caries-free vs. caries-active subjects. Eur J Oral Sci (2007) 1.13

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen. Scand J Infect Dis (2004) 1.06

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. AIDS (2002) 1.04

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J Infect Dis (2013) 1.03

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther (2005) 1.02

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol (2012) 0.99

Paradigm shift in Sweden from tonsillectomy to tonsillotomy for children with upper airway obstructive symptoms due to tonsillar hypertrophy. Eur Arch Otorhinolaryngol (2013) 0.98

Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol (2013) 0.98

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis (2005) 0.98

Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy. Antivir Ther (2006) 0.97

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation (2013) 0.95

pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. AIDS Res Hum Retroviruses (2003) 0.95

Tonsil surgery efficiently relieves symptoms: analysis of 54 696 patients in the National Tonsil Surgery Register in Sweden. Acta Otolaryngol (2012) 0.92

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol (2013) 0.91

The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients. Eur J Clin Pharmacol (2009) 0.91

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy. Scand J Infect Dis (2012) 0.89

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol (2010) 0.89

Influencing self-rated health among adolescent girls with dance intervention: a randomized controlled trial. JAMA Pediatr (2013) 0.89

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol (2007) 0.87

Are trends in work and health conditions interrelated? A study of Swedish hospital employees in the 1990s. J Occup Health Psychol (2005) 0.86

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol (2004) 0.86

Intermittent versus indwelling urinary catheterisation in hip surgery patients: a randomised controlled trial with cost-effectiveness analysis. Int J Nurs Stud (2013) 0.85

Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review. J Med Case Rep (2011) 0.84

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infect Dis (2006) 0.83

Reduced risk of primary postoperative hemorrhage after tonsil surgery in Sweden: results from the National Tonsil Surgery Register in Sweden covering more than 10 years and 54,696 operations. Laryngoscope (2011) 0.83

Pain as presenting symptom in Lyme neuroborreliosis. Eur J Pain (2003) 0.82

Final pH affects the interference capacity of naturally occurring oral Lactobacillus strains against mutans streptococci. Arch Oral Biol (2009) 0.82

Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol (2013) 0.82

Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy). BMC Infect Dis (2011) 0.82

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol (2004) 0.82

Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates. AIDS Res Hum Retroviruses (2009) 0.81

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report. BMC Infect Dis (2006) 0.79

The effectiveness of proactive telephone support provided to breastfeeding mothers of preterm infants: study protocol for a randomized controlled trial. BMC Pediatr (2013) 0.79

Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic subtypes. PLoS One (2008) 0.77

Bacterial interference in upper respiratory tract infections: a systematic review. Am J Rhinol Allergy (2011) 0.77

The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis. Biochem Biophys Res Commun (2011) 0.77

Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study. PLoS One (2013) 0.76

[Bell palsy: Exclude neuroborreliosis prior to cortisone administration]. Lakartidningen (2008) 0.75

[Penicillin V is the first choice in the treatment of erythema migrans]. Lakartidningen (2006) 0.75

[Treatment of acute otitis media--our article does not conflict with the consensus statement]. Lakartidningen (2004) 0.75

Cost-utility analysis of a dance intervention for adolescent girls with internalizing problems. Cost Eff Resour Alloc (2013) 0.75

Solid-phase synthesis of a 6-phenylquinolin-2(1H)-one library directed toward nuclear hormone receptors. J Comb Chem (2005) 0.75

[Counterproductive not to treat streptococcal throat infection]. Lakartidningen (2011) 0.75

[Is neuroborreliosis as a cause of facial paralysis missed?]. Lakartidningen (2005) 0.75

Outcome of 8-hour dosing intervals with beta-lactam antibiotics in adult acute bacterial meningitis. Scand J Infect Dis (2006) 0.75

[High-dose immunoglobulin--life-saving in invasive group A streptococcal infection. Report of eleven cases with only one fatality]. Lakartidningen (2004) 0.75

[Otitis consensus must be adapted to practical reality. Reduced utilization of antibiotics, sure, but not to the price of reduced diagnostics]. Lakartidningen (2007) 0.75

Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection. AIDS Res Hum Retroviruses (2004) 0.75